David Shaw’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.2M | Buy |
+40,031
| New | +$10.5M | 0.01% | 1718 |
|
|
2025
Q2 | – | Sell |
-31,376
| Closed | -$7.3M | – | 4553 |
|
|
2025
Q1 | $7.3M | Sell |
31,376
-24,392
| -44% | -$5.92M | 0.01% | 1632 |
|
|
2024
Q4 | $12.8M | Sell |
55,768
-5,815
| -9% | -$1.33M | 0.01% | 1326 |
|
|
2024
Q3 | $13.8M | Sell |
61,583
-9,497
| -13% | -$2.09M | 0.01% | 1219 |
|
|
2024
Q2 | $14.5M | Buy |
71,080
+17,842
| +34% | +$3.63M | 0.01% | 1101 |
|
|
2024
Q1 | $11.6M | Buy |
53,238
+19,601
| +58% | +$4.32M | 0.01% | 1267 |
|
|
2023
Q4 | $7.65M | Buy |
+33,637
| New | +$7.07M | 0.01% | 1584 |
|
|
2023
Q3 | – | Sell |
-49,042
| Closed | -$10.3M | – | 4381 |
|
|
2023
Q2 | $10.2M | Buy |
49,042
+13,757
| +39% | +$2.67M | 0.01% | 1330 |
|
|
2023
Q1 | $6.95M | Sell |
35,285
-102,372
| -74% | -$21.1M | 0.01% | 1666 |
|
|
2022
Q4 | $27.8M | Sell |
137,657
-510,532
| -79% | -$99.8M | 0.03% | 709 |
|
|
2022
Q3 | $114M | Sell |
648,189
-154,650
| -19% | -$31.7M | 0.14% | 144 |
|
|
2022
Q2 | $162M | Sell |
802,839
-77,377
| -9% | -$16.5M | 0.19% | 81 |
|
|
2022
Q1 | $199M | Buy |
880,216
+529,575
| +151% | +$125M | 0.19% | 90 |
|
|
2021
Q4 | $94.7M | Buy |
350,641
+165,337
| +89% | +$40.9M | 0.08% | 298 |
|
|
2021
Q3 | $44.8M | Sell |
185,304
-38,533
| -17% | -$9.71M | 0.04% | 581 |
|
|
2021
Q2 | $53M | Buy |
223,837
+145,432
| +185% | +$33.1M | 0.05% | 509 |
|
|
2021
Q1 | $17.2M | Sell |
78,405
-310,730
| -80% | -$62.4M | 0.02% | 1020 |
|
|
2020
Q4 | $68M | Buy |
389,135
+73,739
| +23% | +$12.7M | 0.06% | 382 |
|
|
2020
Q3 | $51M | Buy |
315,396
+310,136
| +5,896% | +$49.2M | 0.05% | 414 |
|
|
2020
Q2 | $751K | Sell |
5,260
-25,766
| -83% | -$3.56M | ﹤0.01% | 3118 |
|
|
2020
Q1 | $3.37M | Sell |
31,026
-109,557
| -78% | -$15.8M | 0.01% | 1766 |
|
|
2019
Q4 | $20.4M | Buy |
140,583
+124,959
| +800% | +$18M | 0.02% | 808 |
|
|
2019
Q3 | $2.25M | Buy |
15,624
+12,394
| +384% | +$1.81M | ﹤0.01% | 2258 |
|
|
2019
Q2 | $480K | Sell |
3,230
-76,071
| -96% | -$10.6M | ﹤0.01% | 3099 |
|
|
2019
Q1 | $10.4M | Buy |
79,301
+45,748
| +136% | +$5.64M | 0.01% | 1082 |
|
|
2018
Q4 | $3.64M | Buy |
33,553
+9,555
| +40% | +$1.28M | 0.01% | 1722 |
|
|
2018
Q3 | $3.58M | Sell |
23,998
-32,238
| -57% | -$4.9M | ﹤0.01% | 1789 |
|
|
2018
Q2 | $8.67M | Sell |
56,236
-283,504
| -83% | -$42.8M | 0.01% | 1171 |
|
|
2018
Q1 | $47.2M | Sell |
339,740
-58,639
| -15% | -$8.61M | 0.06% | 365 |
|
|
2017
Q4 | $54.6M | Buy |
398,379
+172,383
| +76% | +$22.8M | 0.08% | 327 |
|
|
2017
Q3 | $29.3M | Sell |
225,996
-146,248
| -39% | -$19.5M | 0.05% | 472 |
|
|
2017
Q2 | $49.3M | Buy |
372,244
+47,961
| +15% | +$5.87M | 0.08% | 293 |
|
|
2017
Q1 | $40M | Buy |
324,283
+168,259
| +108% | +$19.9M | 0.07% | 342 |
|
|
2016
Q4 | $17.2M | Sell |
156,024
-16,640
| -10% | -$1.85M | 0.03% | 687 |
|
|
2016
Q3 | $20.4M | Buy |
172,664
+41,559
| +32% | +$4.9M | 0.04% | 566 |
|
|
2016
Q2 | $14.7M | Sell |
131,105
-32,139
| -20% | -$3.46M | 0.03% | 672 |
|
|
2016
Q1 | $16.4M | Buy |
163,244
+130,518
| +399% | +$12.5M | 0.03% | 625 |
|
|
2015
Q4 | $3.48M | Buy |
32,726
+23,251
| +245% | +$2.4M | 0.01% | 1701 |
|
|
2015
Q3 | $883K | Sell |
9,475
-287,709
| -97% | -$29.8M | ﹤0.01% | 2684 |
|
|
2015
Q2 | $30.9M | Buy |
297,184
+196,816
| +196% | +$20.5M | 0.05% | 474 |
|
|
2015
Q1 | $10.9M | Buy |
100,368
+82,335
| +457% | +$8.47M | 0.02% | 915 |
|
|
2014
Q4 | $1.67M | Buy |
+18,033
| New | +$1.59M | ﹤0.01% | 2418 |
|
|
2014
Q3 | – | Sell |
-46,770
| Closed | -$4.11M | – | 4260 |
|
|
2014
Q2 | $4.11M | Sell |
46,770
-13,758
| -23% | -$1.19M | 0.01% | 1764 |
|
|
2014
Q1 | $5.11M | Sell |
60,528
-33,695
| -36% | -$2.69M | 0.01% | 1564 |
|
|
2013
Q4 | $7.4M | Buy |
+94,223
| New | +$8.04M | 0.01% | 1365 |
|
Other funds holding LH
David Shaw's LH Position: Q2 2026 in Review
David Shaw opened a new position in Labcorp (LH) in Q2 2026: 40,031 shares worth $11.2M. The stake represents 0.01% of the portfolio and ranks #1718 among its holdings. This is a return to the name: David Shaw previously reported a position in LH as recently as Q1 2025.
David Shaw first reported a position in LH in Q4 2013 and has held it in 45 quarters since. The position peaked at $199M in Q1 2022. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- David Shaw held 40,031 shares of Labcorp worth $11.2M as of Q2 2026.
- Labcorp was a new David Shaw position in Q2 2026.
- Labcorp made up 0.01% of David Shaw's portfolio in Q2 2026, its #1718 holding.
- David Shaw first reported a position in Labcorp in Q4 2013 and has held it in 45 quarters since.
- David Shaw's Labcorp position peaked at $199M in Q1 2022.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.